Fig 1.
Schematic view of cytofkit pipeline.
The cytofkit pipeline consists of four major components: (1) pre-processing, (2) cell subset detection, (3) cell subset visualization and interpretation and (4) inference of the relatedness between cell subsets.
Fig 2.
Workflow of ClusterX for mass cytometry data clustering.
(a) depict the workflow of ClusterX for mass cytometry data clustering, which contains four steps: (i) t-SNE dimensionality reduction (ii) estimate the local density on the t-SNE map (iii) detect the density peaks represented as cluster centers and (iv) assign the remaining cells to clusters. (b) Explains the local density estimation method. (c) Illustrate the cluster assigning step using two peaks, peak1 and peak 2. Each point is a cell and the color intensity represents the local density of the cell. Then each cell is assigned to be the same cluster as its nearest neighbor cell which has higher density than it.
Fig 3.
The appearance of the GUI for cytofkit.
The GUI provides full options of cytofkit with help buttons explaining the meaning of each parameter.
Fig 4.
The appearance of the shiny APP for cytofkit.
The shiny APP is designed to provide interactively visualization and exploration the cytofkit analysis results. It is integrated into cytofkit package and also a stand-alone online application.
Fig 5.
Comparison of dimensionality reduction methods.
PCA, ISOMAP and t-SNE are performed on the CD14−CD19− PBMCs dataset and the CD4+ T cell dataset, respectively. In each panel, Cells are plotted using the first two dimensions of the dimensionality-transformed data and color coded by gated populations. (a) Plot of manually gated CD4+, CD8+, γδT, CD3+CD56+ NKT and CD3−CD56+ NK cell populations from the CD14−CD19− PBMCs dataset using PCA, ISOMAP, and t-SNE. (b) Plot of manually gated naïve (CD45RA+CCR7+CD45RO-), TH1 (IFN-γ+), TH17 (IL-17A+) and TFH (CXCR5hiPD-1hi) cell populations from the CD4+ T cell dataset using PCA, ISOMAP, and t-SNE.
Fig 6.
Comparison of clustering methods.
Each panel represents one clustering results mapped on the t-SNE plot; from left to right they are (a) ClusterX, (b) DensVM and (c) PhenoGraph. Clusters were annotated by different colors and with cluster ID at the center of the cluster.
Table 1.
Precision, recall and F-measure of each clustering method by comparing cluster results to manually gated populations of CD4+, CD8+, γδT, NK and NKT cells from the CD14−CD19− PBMCs dataset.
Fig 7.
Clusters annotation with heat map.
Heat maps show median marker expression of clusters detected by (a) ClusterX, (b) DensVM and (c) PhenoGraph respectively. Heat map row labels represent the cluster IDs and column labels show the marker names. Clusters are annotated by its expression profile in (a).
Fig 8.
Assessing ISOMAP, diffusion map and t-SNE for inference of subset relationship.
Three subsamples are down-sampled from the CD14−CD19− PBMCs dataset with equal cell number of 10000. From top to bottom row, the relationship of Cluster X clusters is visualized by t-SNE, ISOMAP and diffusion map on each of the subsample. Cells are color-coded by ClusterX clusters, and cluster IDs are added at the center of each cluster.
Fig 9.
(a) ISOMAP and diffusion map plots of the down-sampled subsets. Cells are color-coded by ClusterX clusters. Cluster IDs are labeled at the center of each cluster (b) Plots of the expression level of marker Perforin using ISOMAP and diffusion map. Estimated progression among annotated subsets γδ Vd+, γδ Vd−, CD8 Eff, NKT and NK are added on the plots. (c) The expression profiles of marker Perforin and GranzymeB for cluster 11, 12, 13, 14 and 15 are visualized on the second component of ISOMAP and diffusion map (reversed order). The regression line estimated using the generalized linear model (GLM) is added for each marker.